Edwards Lifesciences - the leader in heart valves
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
First United States treatment with J-Valve TAVI device
2019年1月11日 · The J-Valve features a proprietary anchor mechanism that is flexibly linked to a self-expanding stent frame to uniquely attach to the failing native heart valve. The J-Valve does not require calcification of the native valve for fixation.
J-Valve Transcatheter Treatment of Native Valve Aortic …
2023年5月8日 · We report the first-in-human compassionate use of J-Valve for the treatment of severe, symptomatic AR in a 43-year-old man after continuous-flow LVAD (HeartMate III; Abbott Vascular) implantation (Figure 1).
It suggests that the J-Valve system is a prom-ising alternative therapy in high-risk patients. AI. The J-Valve system is a self-expandable transcatheter valve with 3 U-shaped anatomically orientating claspers. The clasper and the valve are deployed independently during implantation.
Transcatheter Treatment of Native Aortic Valve Regurgitation:
Compassionate use of a novel transcatheter valve (J-Valve) designed for the treatment of patients with AR was associated with encouraging procedural outcomes and excellent hemodynamic status to 1-year postimplantation.
Transapical Transcatheter Valve Replacement Using J-Valve …
The J-Valve system (Jie ChengMedical Technologies, Suzhou, China) is designed specifically for transapical transcatheter aortic valve replacement and has three U-shaped graspers. With the unique structure, the J-Valve is suitable for both aortic stenosis and aortic regurgitation.
Transcatheter Aortic Valve Implantation With J-Valve: 2-Year …
This study demonstrated good midterm outcomes of transcatheter aortic valve implantation with the J-Valve system in the treatment of patients with either AS or AI. It suggests that the J-Valve system is a promising alternative therapy in high-risk patients.
Transfemoral TAVI device gains US FDA breakthrough status for …
2023年8月1日 · The J-Valve transcatheter aortic valve implant (TAVI) procedure is performed through a minimally invasive transvascular approach, without the need for open-heart procedure or extracorporeal circulation.
Transcatheter aortic valve implantation (TAVI) has evolved as a routine procedure to treat selected high-risk patients with severe aortic stenosis. The new J-ValveTM prosthesis is designed for antegrade transapical implantation, it is characterized by a porcine aortic prosthesis attaching to a self-expandable Nitinol stent.
First-in-human experience of a new-generation transfemoral ...
The TF J-Valve system is a novel transcatheter heart valve system with leaflet-securing anchor rings. It may be well suited to patients with non-calcified aortic valve disease and those at risk of coronary obstruction.
- 某些结果已被删除